Negative regulation of cytokine signaling

Cytokines use complex signaling cascades to elicit their biological effects, many of which involve phosphorylation as a mechanism of activation. Rapid and efficient attenuation of cytokine signals is crucial to maintaining regulation of these processes and to preventing toxic side effects. Phosphatases have been shown to be involved in these regulatory processes, but more recent research has seen the discovery of two new families of negative regulators, the suppressor of cytokine signaling (SOCS) and protein inhibitors of signal transducer and activator of transcription (STAT) (PIAS) protein families. SOCS proteins are induced by and inhibit many cytokine‐signaling systems in a classic negative‐feedback loop, and the generation of transgenic and knockout models has greatly increased our understanding of their physiological functions. PIAS proteins interact with the transcriptional mediators of cytokine action, the STATs, to suppress their DNA‐binding activity. These three classes of molecules form what is now emerging as an integrated system for deactivating cytokine signaling at a number of levels, from the receptor to the transcription factor.

[1]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[2]  Josef M. Penninger,et al.  CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling , 2001, Nature.

[3]  H. Pendeville,et al.  SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.

[4]  D. Hilton,et al.  Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. , 1999, Journal of immunology.

[5]  D. Alexander,et al.  The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. , 2000, Seminars in immunology.

[6]  Y. Mao,et al.  Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo. , 1999, Endocrinology.

[7]  A. Stavreus-Evers,et al.  Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. , 1999, Endocrinology.

[8]  N. Copeland,et al.  A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.

[9]  W. Kaelin,et al.  The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. , 1998, Genes & development.

[10]  A. Elefanty,et al.  Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[12]  F. Hirayama,et al.  Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1 alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Flier,et al.  Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. , 1999, Endocrinology.

[14]  A. Yoshimura,et al.  Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. , 1999, Blood.

[15]  D. Wylie,et al.  DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance. , 1997, Journal of immunology.

[16]  T. Takenawa,et al.  A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs. , 1997, Biochemical and biophysical research communications.

[17]  K. Siminovitch,et al.  Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. , 2000, Seminars in immunology.

[18]  D. Waxman,et al.  Role of the Cytokine-inducible SH2 Protein CIS in Desensitization of STAT5b Signaling by Continuous Growth Hormone* , 2000, The Journal of Biological Chemistry.

[19]  Paul J Hertzog,et al.  SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.

[20]  T. Yi,et al.  Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. , 1997, Experimental hematology.

[21]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[22]  P. Kelly,et al.  Inhibition and Restoration of Prolactin Signal Transduction by Suppressors of Cytokine Signaling* , 1999, The Journal of Biological Chemistry.

[23]  J. Flier,et al.  Activation of SOCS-3 Messenger Ribonucleic Acid in the Hypothalamus by Ciliary Neurotrophic Factor. , 1999, Endocrinology.

[24]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[25]  S. Park,et al.  Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells. , 2000, Molecular Endocrinology.

[26]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[27]  Y. Uchiyama,et al.  Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Ryffel,et al.  The viable motheaten (mev) mouse--a new model for arthritis. , 1994, Journal of Autoimmunity.

[29]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[30]  B. R. Dey,et al.  Interaction of Human Suppressor of Cytokine Signaling (SOCS)-2 with the Insulin-like Growth Factor-I Receptor* , 1998, The Journal of Biological Chemistry.

[31]  D. Lejeune,et al.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. , 2001, The Biochemical journal.

[32]  C. Lang,et al.  Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. , 1995, The American journal of physiology.

[33]  J. Flier,et al.  The Role of SOCS-3 in Leptin Signaling and Leptin Resistance* , 1999, The Journal of Biological Chemistry.

[34]  I. Gresser Can interferon induce disease? , 1982, Interferon.

[35]  H. Dickensheets,et al.  Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. , 1999, Blood.

[36]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. R. Dey,et al.  Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. , 2000, Biochemical and biophysical research communications.

[38]  K. Siminovitch,et al.  Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene , 1993, Nature Genetics.

[39]  S Goelz,et al.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1 , 1995, Molecular and cellular biology.

[40]  W. Alexander,et al.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.

[41]  D. Waxman,et al.  SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[42]  J. Ihle,et al.  Signaling by the Cytokine Receptor Superfamily a , 1998, Annals of the New York Academy of Sciences.

[43]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[45]  B. Neel,et al.  Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1 , 1996, Molecular and cellular biology.

[46]  M. Kubo,et al.  Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice , 1999, Molecular and Cellular Biology.

[47]  E. Hooghe-Peters,et al.  Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines , 2000, Journal of Neuroimmunology.

[48]  Y. Miyakawa,et al.  Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. , 2000, Blood.

[49]  A. Yoshimura,et al.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[50]  T. Naka,et al.  Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. , 1997, Biochemical and biophysical research communications.

[51]  B. Gao,et al.  IL‐10 attenuates IFN‐α‐activated STAT1 in the liver: involvement of SOCS2 and SOCS3 , 2000 .

[52]  D. Hilton,et al.  Growth Hormone Preferentially Induces the Rapid, Transient Expression of SOCS-3, a Novel Inhibitor of Cytokine Receptor Signaling* , 1998, The Journal of Biological Chemistry.

[53]  R. Palmiter,et al.  Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver , 1984, Cell.

[54]  S. Akira,et al.  Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation , 2001, The Journal of experimental medicine.

[55]  A. Bernstein,et al.  Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1 , 1996, Nature Genetics.

[56]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[57]  A. Yoshimura,et al.  CIS3/SOCS-3 Suppresses Erythropoietin (EPO) Signaling by Binding the EPO Receptor and JAK2* , 2000, The Journal of Biological Chemistry.

[58]  S. Melmed,et al.  Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis. , 1999, Endocrinology.

[59]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[60]  H. Dickensheets,et al.  Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .

[61]  Dana P. Ascherman,et al.  CIS Associates with the Interleukin-2 Receptor β Chain and Inhibits Interleukin-2-dependent Signaling* , 1999, The Journal of Biological Chemistry.

[62]  S. Ziegler,et al.  Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. , 1999, Journal of immunology.

[63]  J. Tavernier,et al.  Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor , 2000, FEBS letters.

[64]  藤本 穰 Defective Thymocyte Development and Perturbed Homeostasis of T cells in STAT-Induced STAT Inhibitor-1/Suppressors of Cytokine Signaling-1 Transgenic mice , 2001 .

[65]  S. Tomić,et al.  SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor , 1999, Molecular and Cellular Endocrinology.

[66]  J. Gustafsson,et al.  Cis desensitizes GH induced Stat5 signaling in rat liver cells , 1999, Molecular and Cellular Endocrinology.

[67]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[68]  X. Shen,et al.  IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. , 2000, FEBS letters.

[69]  W. Alexander,et al.  Twenty proteins containing a C-terminal SOCS box form five structural classes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Carson,et al.  A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer , 2000, Oncogene.

[71]  T. Naka,et al.  Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[72]  K. Sjögren,et al.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Kolasa,et al.  Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. , 1995, The American journal of physiology.

[75]  J. G. Zhang,et al.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. Aguet,et al.  Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. , 1981, The American journal of pathology.

[77]  F. Magrangeas,et al.  Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3). , 2001, The Biochemical journal.

[78]  A. Kuramoto,et al.  Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. , 1995, Blood.

[79]  K. Shuai,et al.  The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities* , 1998, The Journal of Biological Chemistry.

[80]  V. Emilsson,et al.  Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues , 1999, FEBS letters.

[81]  Wei Zhu,et al.  Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription , 2001, Cell.

[82]  O. Miura,et al.  Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. , 1995, Blood.

[83]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[84]  D. Beier,et al.  Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.

[85]  J. Johnston,et al.  SOCS-3 Is Tyrosine Phosphorylated in Response to Interleukin-2 and Suppresses STAT5 Phosphorylation and Lymphocyte Proliferation , 1999, Molecular and Cellular Biology.

[86]  D. Hilton,et al.  Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. , 1999, Molecular endocrinology.

[87]  G. Ooi,et al.  Role of the Suppressor of Cytokine Signaling-3 in Mediating the Inhibitory Effects of Interleukin-1β on the Growth Hormone-dependent Transcription of the Acid-labile Subunit Gene in Liver Cells* , 2000, The Journal of Biological Chemistry.

[88]  S. Nagata,et al.  Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Johnston,et al.  Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma. , 1999, Journal of immunology.

[90]  A. de la Chapelle,et al.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. G. Zhang,et al.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[92]  H. Sakamoto,et al.  Cloning and characterization of novel CIS family genes. , 1997, Biochemical and biophysical research communications.

[93]  K. Shuai,et al.  Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[95]  M. David,et al.  Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. , 2001, Cell.